Mylan-Rosuvastatin calcium tablets receive Health Canada approval

Mylan-Rosuvastatin is the generic version of Astra Zeneca’s Crestor Tablets, which are used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia.

Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg, had sales of approximately $742m in Canada for the 12 months ending 31 December 2011, according to IMS Health.

Mylan Canada president Dick Guest said according to the Canadian Heart and Stroke Foundation, ‘about 40% of Canadians have high blood cholesterol.’

"Not only does this introduction provide Canadians with access to our quality medicine, it does so at a substantially lower cost. The introduction of generic medicines like Mylan-Rosuvastatin helps to contribute to a sustainable health care system," Guest said.

Mylan Canada currently has 42 product applications pending Health Canada approval, and according to IMS Health these applications represent $3.6bn in annual sales.